Mucormycosis in COVID-19 patients

Mucormycosis, commonly known as 'Black Fungus' which was then a rare fungal infection, has suddenly come to light post the COVID-19- pandemic, more so during the second wave in India. It thus becomes important not only for the medical fraternity but also the general population to build awareness about the same. The present review will focus on the pathophysiology, etiology, outcomes of some case studies, and current treatment methods of mucormycosis infection. Major focus of the current article is on rhino-orbital-cerebral mucormycosis. All the studies included in the present review article was extracted from the PubMed database.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:69

Enthalten in:

Indian journal of ophthalmology - 69(2021), 12 vom: 01. Dez., Seite 3728-3733

Sprache:

Englisch

Beteiligte Personen:

Sundaram, Natarajan [VerfasserIn]
Bhende, Tejas [VerfasserIn]
Yashwant, Runali [VerfasserIn]
Jadhav, Siddhita [VerfasserIn]
Jain, Astha [VerfasserIn]

Links:

Volltext

Themen:

COVID-19
Corticosteroids
Diabetes
Hyperglycemia
Immunosuppression
Journal Article
Ketoacidosis
Mucormycosis
Review
Rhino-orbital-cerebral mucormycosis

Anmerkungen:

Date Completed 03.12.2021

Date Revised 08.03.2022

published: Print

Citation Status MEDLINE

doi:

10.4103/ijo.IJO_1316_21

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM333641558